HPV 9-valent vaccine lot consistency trial for women
Part of Infections clinical trials.
This trial tests whether different batches of the HPV 9-valent vaccine work consistently. It's for Chinese women aged 18 to 30 who have not had any HPV vaccine or abnormal cervical screening results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a Chinese woman between 18 and 30 years old.
- You have no history of sexually transmitted diseases like syphilis or gonorrhea.
- You have never had an abnormal cervical screening or cervical dysplasia (CIN).
- You have not received any HPV vaccine before.
- You are not pregnant or breastfeeding and will use effective birth control during the study.
- You have no serious health conditions or allergies to vaccine components.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a 9-type HPV vaccine to see how well it works, how it helps the body build protection, and whether it’s safe. It’s for healthy Chinese women who have not had HPV vaccination before and meet specific health and timing requirements.
This trial tests an 11-type HPV vaccine to prevent infection from multiple HPV strains. If you enroll, you’ll receive scheduled vaccine doses and have health and gynecologic check-ins to see how well the vaccine works and is tolerated.
This study tests a new HPV vaccine (V503, known as Gardasil 9) in Chinese women who either previously received the bivalent HPV vaccine (Cervarix) more than a year ago or never had any HPV vaccine. The goal is to see if this vaccine can effectively prevent HPV-related diseases.
This study tests a 9-valent HPV vaccine (protects against 9 types of human papillomavirus) in women who have already completed a previous HPV vaccine series. Researchers will check how safe the new vaccine is and how well your immune system responds to it.
This trial studies whether a quadrivalent HPV vaccine is safe and helps the body build protection (immunity) against HPV. It enrolls healthy Chinese females who are not already treated for HPV-related infection.
This study tests if a single dose of the HPV vaccine (Gardasil 9) can lower the amount of HPV virus in women who already have the virus, potentially reducing how easily it spreads. It will help us learn if vaccination can protect partners and communities.
Hear when a new Infection by Human Papilloma Virus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.